

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * aminoglycoside antibiotic metabolic process (GO:0030647) | 9.31508323 |
| 2 | primary alcohol catabolic process (GO:0034310) | 7.24645025 |
| 3 | negative regulation of fibrinolysis (GO:0051918) | 6.72161979 |
| 4 | cellular glucuronidation (GO:0052695) | 6.11079328 |
| 5 | regulation of fibrinolysis (GO:0051917) | 6.07356851 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 6.06173453 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.06173453 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 5.99233828 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.99233828 |
| 10 | regulation of protein activation cascade (GO:2000257) | 5.93136348 |
| 11 | glucuronate metabolic process (GO:0019585) | 5.75652124 |
| 12 | uronic acid metabolic process (GO:0006063) | 5.75652124 |
| 13 | regulation of complement activation (GO:0030449) | 5.59802329 |
| 14 | ethanol oxidation (GO:0006069) | 5.51127371 |
| 15 | protein carboxylation (GO:0018214) | 5.44573873 |
| 16 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.44573873 |
| 17 | complement activation, alternative pathway (GO:0006957) | 5.18602244 |
| 18 | * glycoside metabolic process (GO:0016137) | 4.97387475 |
| 19 | * progesterone metabolic process (GO:0042448) | 4.69711998 |
| 20 | regulation of plasminogen activation (GO:0010755) | 4.69633975 |
| 21 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.67007576 |
| 22 | ethanol metabolic process (GO:0006067) | 4.65660632 |
| 23 | fibrinolysis (GO:0042730) | 4.61549452 |
| 24 | negative regulation of protein activation cascade (GO:2000258) | 4.37730092 |
| 25 | plasma lipoprotein particle clearance (GO:0034381) | 4.36594395 |
| 26 | urea metabolic process (GO:0019627) | 4.35547296 |
| 27 | regulation of cholesterol esterification (GO:0010872) | 4.34877202 |
| 28 | blood coagulation, intrinsic pathway (GO:0007597) | 4.33797175 |
| 29 | exogenous drug catabolic process (GO:0042738) | 4.18509896 |
| 30 | * intestinal cholesterol absorption (GO:0030299) | 4.15981782 |
| 31 | negative regulation of sterol transport (GO:0032372) | 4.11724101 |
| 32 | negative regulation of cholesterol transport (GO:0032375) | 4.11724101 |
| 33 | glyoxylate metabolic process (GO:0046487) | 4.10921586 |
| 34 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.04189388 |
| 35 | primary alcohol metabolic process (GO:0034308) | 3.99354291 |
| 36 | plasma lipoprotein particle remodeling (GO:0034369) | 3.99241755 |
| 37 | protein-lipid complex remodeling (GO:0034368) | 3.99241755 |
| 38 | macromolecular complex remodeling (GO:0034367) | 3.99241755 |
| 39 | nitrogen cycle metabolic process (GO:0071941) | 3.97587675 |
| 40 | low-density lipoprotein particle clearance (GO:0034383) | 3.96661416 |
| 41 | drug catabolic process (GO:0042737) | 3.95283625 |
| 42 | cysteine metabolic process (GO:0006534) | 3.91839080 |
| 43 | urea cycle (GO:0000050) | 3.90660628 |
| 44 | * quinone metabolic process (GO:1901661) | 3.88845303 |
| 45 | flavonoid metabolic process (GO:0009812) | 3.86623148 |
| 46 | plasma lipoprotein particle assembly (GO:0034377) | 3.84863470 |
| 47 | negative regulation of blood coagulation (GO:0030195) | 3.80179304 |
| 48 | negative regulation of hemostasis (GO:1900047) | 3.80179304 |
| 49 | aromatic amino acid family catabolic process (GO:0009074) | 3.76519485 |
| 50 | cholesterol efflux (GO:0033344) | 3.75436846 |
| 51 | negative regulation of lipase activity (GO:0060192) | 3.73736116 |
| 52 | triglyceride homeostasis (GO:0070328) | 3.73204403 |
| 53 | acylglycerol homeostasis (GO:0055090) | 3.73204403 |
| 54 | acute-phase response (GO:0006953) | 3.73121725 |
| 55 | low-density lipoprotein particle remodeling (GO:0034374) | 3.68325267 |
| 56 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.65534966 |
| 57 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.65534966 |
| 58 | positive regulation of blood coagulation (GO:0030194) | 3.64501195 |
| 59 | positive regulation of hemostasis (GO:1900048) | 3.64501195 |
| 60 | negative regulation of complement activation (GO:0045916) | 3.63910483 |
| 61 | protein activation cascade (GO:0072376) | 3.63857928 |
| 62 | regulation of apoptotic cell clearance (GO:2000425) | 3.63766108 |
| 63 | epoxygenase P450 pathway (GO:0019373) | 3.61722382 |
| 64 | negative regulation of coagulation (GO:0050819) | 3.58121388 |
| 65 | protein-lipid complex assembly (GO:0065005) | 3.57273886 |
| 66 | high-density lipoprotein particle remodeling (GO:0034375) | 3.56797776 |
| 67 | * bile acid metabolic process (GO:0008206) | 3.54294026 |
| 68 | * C21-steroid hormone metabolic process (GO:0008207) | 3.52261268 |
| 69 | phospholipid efflux (GO:0033700) | 3.50573618 |
| 70 | regulation of triglyceride catabolic process (GO:0010896) | 3.48530244 |
| 71 | complement activation, classical pathway (GO:0006958) | 3.47420025 |
| 72 | drug metabolic process (GO:0017144) | 3.46883751 |
| 73 | negative regulation of wound healing (GO:0061045) | 3.44911939 |
| 74 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.44676834 |
| 75 | bile acid biosynthetic process (GO:0006699) | 3.42404138 |
| 76 | positive regulation of extracellular matrix organization (GO:1903055) | 3.38699797 |
| 77 | positive regulation of coagulation (GO:0050820) | 3.38593689 |
| 78 | * retinal metabolic process (GO:0042574) | 3.37567189 |
| 79 | alpha-linolenic acid metabolic process (GO:0036109) | 3.36137708 |
| 80 | cyclooxygenase pathway (GO:0019371) | 3.32361483 |
| 81 | plasma lipoprotein particle organization (GO:0071827) | 3.32216217 |
| 82 | glutamate metabolic process (GO:0006536) | 3.30397795 |
| 83 | complement activation (GO:0006956) | 3.27717905 |
| 84 | acylglycerol catabolic process (GO:0046464) | 3.27655737 |
| 85 | neutral lipid catabolic process (GO:0046461) | 3.27655737 |
| 86 | response to nitrosative stress (GO:0051409) | 3.25762689 |
| 87 | reverse cholesterol transport (GO:0043691) | 3.23936614 |
| 88 | tyrosine metabolic process (GO:0006570) | 3.23321969 |
| 89 | regulation of humoral immune response (GO:0002920) | 3.21200534 |
| 90 | protein-lipid complex subunit organization (GO:0071825) | 3.20358096 |
| 91 | amino-acid betaine metabolic process (GO:0006577) | 3.20142090 |
| 92 | phenylpropanoid metabolic process (GO:0009698) | 3.17926556 |
| 93 | drug transmembrane transport (GO:0006855) | 3.13564097 |
| 94 | triglyceride catabolic process (GO:0019433) | 3.11686923 |
| 95 | response to prostaglandin (GO:0034694) | 3.10896129 |
| 96 | omega-hydroxylase P450 pathway (GO:0097267) | 3.09995641 |
| 97 | L-ascorbic acid metabolic process (GO:0019852) | 3.09790531 |
| 98 | * polyketide metabolic process (GO:0030638) | 10.6235793 |
| 99 | * doxorubicin metabolic process (GO:0044598) | 10.6235793 |
| 100 | * daunorubicin metabolic process (GO:0044597) | 10.6235793 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.61052829 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.57045418 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.37233193 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.52590212 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.48656220 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.97922493 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.71579409 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.20815543 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.18163835 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.04028637 |
| 11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.02658137 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.02272180 |
| 13 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.60405010 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.56467609 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.47066891 |
| 16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.26449218 |
| 17 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.06674449 |
| 18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.99649217 |
| 19 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.92438853 |
| 20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.92430144 |
| 21 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.90559222 |
| 22 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.82899307 |
| 23 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.77107540 |
| 24 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.70290843 |
| 25 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.70257845 |
| 26 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.54386098 |
| 27 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.52467979 |
| 28 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.51286923 |
| 29 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.51252885 |
| 30 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.48507602 |
| 31 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.47977426 |
| 32 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.46694630 |
| 33 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.46328539 |
| 34 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.44280293 |
| 35 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.44280293 |
| 36 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.42135012 |
| 37 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.40990854 |
| 38 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.34132932 |
| 39 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.31713330 |
| 40 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.29516587 |
| 41 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.27742213 |
| 42 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.26658505 |
| 43 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.25650459 |
| 44 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.20577874 |
| 45 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.17406595 |
| 46 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.16610601 |
| 47 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.15196043 |
| 48 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.12964914 |
| 49 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.12272460 |
| 50 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.10630929 |
| 51 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.05594177 |
| 52 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.04249625 |
| 53 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.02925815 |
| 54 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.02787485 |
| 55 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.02195440 |
| 56 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01310975 |
| 57 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.97673163 |
| 58 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.97314000 |
| 59 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96980969 |
| 60 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.96863017 |
| 61 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95029735 |
| 62 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94871349 |
| 63 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.94811820 |
| 64 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.93100662 |
| 65 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.90802498 |
| 66 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.90737894 |
| 67 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.90108394 |
| 68 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.90068634 |
| 69 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89322760 |
| 70 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.89305273 |
| 71 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.89305273 |
| 72 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.86682102 |
| 73 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.83138569 |
| 74 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.83138569 |
| 75 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.82695882 |
| 76 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.81481808 |
| 77 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.81353376 |
| 78 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.79576526 |
| 79 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.79550511 |
| 80 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.78901901 |
| 81 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.78391685 |
| 82 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.77712442 |
| 83 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.77326127 |
| 84 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76330744 |
| 85 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.75874334 |
| 86 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.74942972 |
| 87 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.74891978 |
| 88 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74684998 |
| 89 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.72839792 |
| 90 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.72238713 |
| 91 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.70366532 |
| 92 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.70294310 |
| 93 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.69858550 |
| 94 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.69178075 |
| 95 | ATF3_27146783_Chip-Seq_COLON_Human | 0.68402636 |
| 96 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.68212277 |
| 97 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.67655810 |
| 98 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.67586381 |
| 99 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.66551597 |
| 100 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.66015468 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.52273578 |
| 2 | MP0005365_abnormal_bile_salt | 5.51691809 |
| 3 | MP0005360_urolithiasis | 4.83477001 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.59650506 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.58693391 |
| 6 | MP0003195_calcinosis | 3.59598906 |
| 7 | MP0003868_abnormal_feces_composition | 3.37973211 |
| 8 | MP0001666_abnormal_nutrient_absorption | 3.26435919 |
| 9 | MP0003252_abnormal_bile_duct | 3.22733911 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.09000503 |
| 11 | MP0008438_abnormal_cutaneous_collagen | 2.53466655 |
| 12 | MP0009840_abnormal_foam_cell | 2.44353404 |
| 13 | MP0005670_abnormal_white_adipose | 2.35627918 |
| 14 | MP0005332_abnormal_amino_acid | 2.19444947 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.03184483 |
| 16 | MP0004272_abnormal_basement_membrane | 1.94458792 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 1.92312719 |
| 18 | MP0000609_abnormal_liver_physiology | 1.83785234 |
| 19 | MP0003806_abnormal_nucleotide_metabolis | 1.80039204 |
| 20 | MP0002876_abnormal_thyroid_physiology | 1.70653102 |
| 21 | MP0001661_extended_life_span | 1.67023831 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 1.66567480 |
| 23 | MP0003186_abnormal_redox_activity | 1.61909856 |
| 24 | MP0002971_abnormal_brown_adipose | 1.50490152 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 1.47286003 |
| 26 | MP0005408_hypopigmentation | 1.46999585 |
| 27 | MP0003950_abnormal_plasma_membrane | 1.42069750 |
| 28 | MP0005058_abnormal_lysosome_morphology | 1.38964914 |
| 29 | MP0005666_abnormal_adipose_tissue | 1.35788529 |
| 30 | MP0009697_abnormal_copulation | 1.35550057 |
| 31 | MP0005164_abnormal_response_to | 1.32944771 |
| 32 | MP0005451_abnormal_body_composition | 1.29701948 |
| 33 | MP0005275_abnormal_skin_tensile | 1.29055127 |
| 34 | MP0005503_abnormal_tendon_morphology | 1.25982567 |
| 35 | MP0005319_abnormal_enzyme/_coenzyme | 1.20867119 |
| 36 | MP0009780_abnormal_chondrocyte_physiolo | 1.20508707 |
| 37 | MP0001915_intracranial_hemorrhage | 1.19512715 |
| 38 | MP0010368_abnormal_lymphatic_system | 1.17665136 |
| 39 | MP0009643_abnormal_urine_homeostasis | 1.16660403 |
| 40 | MP0003566_abnormal_cell_adhesion | 1.15413604 |
| 41 | MP0000604_amyloidosis | 1.14275217 |
| 42 | MP0003656_abnormal_erythrocyte_physiolo | 1.13182807 |
| 43 | MP0002132_abnormal_respiratory_system | 1.10137211 |
| 44 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.08697171 |
| 45 | MP0005257_abnormal_intraocular_pressure | 1.08565432 |
| 46 | MP0005375_adipose_tissue_phenotype | 1.08171544 |
| 47 | MP0005023_abnormal_wound_healing | 1.07015303 |
| 48 | MP0003705_abnormal_hypodermis_morpholog | 1.00990404 |
| 49 | MP0001764_abnormal_homeostasis | 1.00325717 |
| 50 | MP0000598_abnormal_liver_morphology | 0.98559298 |
| 51 | MP0004130_abnormal_muscle_cell | 0.92385069 |
| 52 | MP0000003_abnormal_adipose_tissue | 0.90516388 |
| 53 | MP0006054_spinal_hemorrhage | 0.88412590 |
| 54 | MP0002089_abnormal_postnatal_growth/wei | 0.87792718 |
| 55 | MP0000566_synostosis | 0.85401025 |
| 56 | MP0009115_abnormal_fat_cell | 0.84971403 |
| 57 | MP0005083_abnormal_biliary_tract | 0.84939655 |
| 58 | MP0003959_abnormal_lean_body | 0.81882562 |
| 59 | MP0005334_abnormal_fat_pad | 0.80650741 |
| 60 | MP0002970_abnormal_white_adipose | 0.80621443 |
| 61 | MP0003690_abnormal_glial_cell | 0.80214289 |
| 62 | MP0004883_abnormal_blood_vessel | 0.78956253 |
| 63 | MP0005636_abnormal_mineral_homeostasis | 0.78740205 |
| 64 | MP0003011_delayed_dark_adaptation | 0.78343559 |
| 65 | MP0009642_abnormal_blood_homeostasis | 0.77428403 |
| 66 | MP0004185_abnormal_adipocyte_glucose | 0.76678389 |
| 67 | MP0005376_homeostasis/metabolism_phenot | 0.75262237 |
| 68 | MP0002078_abnormal_glucose_homeostasis | 0.71931672 |
| 69 | MP0004782_abnormal_surfactant_physiolog | 0.70474810 |
| 70 | MP0000858_altered_metastatic_potential | 0.69938732 |
| 71 | MP0009763_increased_sensitivity_to | 0.69729384 |
| 72 | MP0003122_maternal_imprinting | 0.68180553 |
| 73 | MP0003329_amyloid_beta_deposits | 0.67750015 |
| 74 | MP0002295_abnormal_pulmonary_circulatio | 0.66157958 |
| 75 | MP0008469_abnormal_protein_level | 0.66045128 |
| 76 | MP0002909_abnormal_adrenal_gland | 0.65854001 |
| 77 | MP0005167_abnormal_blood-brain_barrier | 0.65604794 |
| 78 | MP0001756_abnormal_urination | 0.63026271 |
| 79 | MP0000249_abnormal_blood_vessel | 0.62682718 |
| 80 | MP0002168_other_aberrant_phenotype | 0.62590030 |
| 81 | MP0002060_abnormal_skin_morphology | 0.62340401 |
| 82 | MP0005448_abnormal_energy_balance | 0.60561965 |
| 83 | MP0005165_increased_susceptibility_to | 0.59191902 |
| 84 | MP0005464_abnormal_platelet_physiology | 0.59148620 |
| 85 | MP0009053_abnormal_anal_canal | 0.58384528 |
| 86 | MP0000467_abnormal_esophagus_morphology | 0.56598462 |
| 87 | MP0001958_emphysema | 0.56382083 |
| 88 | MP0000013_abnormal_adipose_tissue | 0.56147623 |
| 89 | MP0002933_joint_inflammation | 0.56005736 |
| 90 | MP0003638_abnormal_response/metabolism_ | 0.55816306 |
| 91 | MP0009384_cardiac_valve_regurgitation | 0.55459988 |
| 92 | MP0002108_abnormal_muscle_morphology | 0.54586345 |
| 93 | MP0002896_abnormal_bone_mineralization | 0.54453868 |
| 94 | MP0006138_congestive_heart_failure | 0.52740878 |
| 95 | MP0003941_abnormal_skin_development | 0.51685770 |
| 96 | MP0005535_abnormal_body_temperature | 0.50352804 |
| 97 | MP0003075_altered_response_to | 0.47849230 |
| 98 | MP0008260_abnormal_autophagy | 0.47710658 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.46872338 |
| 100 | MP0005395_other_phenotype | 0.46745982 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 8.42206915 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 7.13857795 |
| 3 | Complement deficiency (HP:0004431) | 6.88103911 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 6.01490394 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.01201450 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.91730880 |
| 7 | Abnormality of complement system (HP:0005339) | 5.82618968 |
| 8 | Conjugated hyperbilirubinemia (HP:0002908) | 5.40056252 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 5.18049621 |
| 10 | Abnormality of the common coagulation pathway (HP:0010990) | 4.89030794 |
| 11 | Glomerulonephritis (HP:0000099) | 4.84482897 |
| 12 | Joint hemorrhage (HP:0005261) | 4.73319681 |
| 13 | Xanthomatosis (HP:0000991) | 4.53209979 |
| 14 | Fat malabsorption (HP:0002630) | 4.13384580 |
| 15 | Vascular calcification (HP:0004934) | 4.08141808 |
| 16 | Hypolipoproteinemia (HP:0010981) | 3.91631219 |
| 17 | Cardiovascular calcification (HP:0011915) | 3.87320687 |
| 18 | Mitral stenosis (HP:0001718) | 3.87288908 |
| 19 | Spontaneous abortion (HP:0005268) | 3.84211270 |
| 20 | Intrahepatic cholestasis (HP:0001406) | 3.72978004 |
| 21 | Steatorrhea (HP:0002570) | 3.63088521 |
| 22 | Abnormal sex determination (HP:0012244) | 3.62976987 |
| 23 | Sex reversal (HP:0012245) | 3.62976987 |
| 24 | Hemorrhage of the eye (HP:0011885) | 3.62677493 |
| 25 | Hypercholesterolemia (HP:0003124) | 3.51081246 |
| 26 | Protrusio acetabuli (HP:0003179) | 3.50789545 |
| 27 | Nephritis (HP:0000123) | 3.38978244 |
| 28 | Hyperlipoproteinemia (HP:0010980) | 3.35398122 |
| 29 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.31336408 |
| 30 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.27123455 |
| 31 | Vertebral compression fractures (HP:0002953) | 3.19986270 |
| 32 | Rickets (HP:0002748) | 3.03747900 |
| 33 | Epidermoid cyst (HP:0200040) | 2.90168293 |
| 34 | Back pain (HP:0003418) | 2.82415987 |
| 35 | Abnormality of the Achilles tendon (HP:0005109) | 2.81561647 |
| 36 | Hydroxyprolinuria (HP:0003080) | 2.77789169 |
| 37 | Abnormality of proline metabolism (HP:0010907) | 2.77789169 |
| 38 | Skin nodule (HP:0200036) | 2.72036975 |
| 39 | Gingival bleeding (HP:0000225) | 2.69884518 |
| 40 | Hypoalphalipoproteinemia (HP:0003233) | 2.67061794 |
| 41 | Myocardial infarction (HP:0001658) | 2.65946186 |
| 42 | Abnormality of the intrinsic pathway (HP:0010989) | 2.65518610 |
| 43 | Arthropathy (HP:0003040) | 2.51848897 |
| 44 | Generalized aminoaciduria (HP:0002909) | 2.49873153 |
| 45 | Purpura (HP:0000979) | 2.44943133 |
| 46 | Abnormality of carpal bone ossification (HP:0006257) | 2.42261933 |
| 47 | Menorrhagia (HP:0000132) | 2.40195879 |
| 48 | Hyperammonemia (HP:0001987) | 2.37299569 |
| 49 | Hepatocellular carcinoma (HP:0001402) | 2.20856240 |
| 50 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.17087746 |
| 51 | Mucopolysacchariduria (HP:0008155) | 2.17087746 |
| 52 | Amyloidosis (HP:0011034) | 2.15514226 |
| 53 | Abnormal delivery (HP:0001787) | 2.12764068 |
| 54 | Osteomalacia (HP:0002749) | 2.11061408 |
| 55 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.10796463 |
| 56 | Vascular tortuosity (HP:0004948) | 2.10126036 |
| 57 | Hyperbilirubinemia (HP:0002904) | 2.05429314 |
| 58 | Tetraparesis (HP:0002273) | 2.01852742 |
| 59 | Increased serum pyruvate (HP:0003542) | 1.97185272 |
| 60 | Arterial tortuosity (HP:0005116) | 1.95074407 |
| 61 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.94715497 |
| 62 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.94715497 |
| 63 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.94715497 |
| 64 | Hypertriglyceridemia (HP:0002155) | 1.94077010 |
| 65 | Polycythemia (HP:0001901) | 1.93951884 |
| 66 | Hypophosphatemic rickets (HP:0004912) | 1.90856797 |
| 67 | Abnormal cartilage morphology (HP:0002763) | 1.86679758 |
| 68 | Reduced antithrombin III activity (HP:0001976) | 1.85768958 |
| 69 | Abnormality of glycolysis (HP:0004366) | 1.85449072 |
| 70 | Premature rupture of membranes (HP:0001788) | 1.84398376 |
| 71 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.83602670 |
| 72 | Thrombophlebitis (HP:0004418) | 1.82035572 |
| 73 | Bifid scrotum (HP:0000048) | 1.81216233 |
| 74 | Abnormality of the acetabulum (HP:0003170) | 1.80828369 |
| 75 | Cervical subluxation (HP:0003308) | 1.80361906 |
| 76 | Increased serum ferritin (HP:0003281) | 1.79858800 |
| 77 | Acanthocytosis (HP:0001927) | 1.77554063 |
| 78 | Facial shape deformation (HP:0011334) | 1.76348537 |
| 79 | Potter facies (HP:0002009) | 1.76348537 |
| 80 | Beaking of vertebral bodies (HP:0004568) | 1.75333714 |
| 81 | Ovoid vertebral bodies (HP:0003300) | 1.72960647 |
| 82 | Flat acetabular roof (HP:0003180) | 1.72004185 |
| 83 | Abnormal ossification of hand bones (HP:0005921) | 1.71823968 |
| 84 | Abnormality of methionine metabolism (HP:0010901) | 1.70318842 |
| 85 | Joint swelling (HP:0001386) | 1.69144232 |
| 86 | Abnormality of iron homeostasis (HP:0011031) | 1.68424121 |
| 87 | Abnormal tarsal ossification (HP:0008369) | 1.68145035 |
| 88 | Abnormal hand bone ossification (HP:0010660) | 1.65848794 |
| 89 | Abnormality of vitamin metabolism (HP:0100508) | 1.64566933 |
| 90 | Hyperglycinemia (HP:0002154) | 1.64136334 |
| 91 | Peritonitis (HP:0002586) | 1.63674617 |
| 92 | Hypoglycemic coma (HP:0001325) | 1.63129559 |
| 93 | Abnormality of nucleobase metabolism (HP:0010932) | 1.62340385 |
| 94 | Glomerulosclerosis (HP:0000096) | 1.61799189 |
| 95 | Elevated alkaline phosphatase (HP:0003155) | 1.60923176 |
| 96 | Abnormal gallbladder physiology (HP:0012438) | 1.58774828 |
| 97 | Cholecystitis (HP:0001082) | 1.58774828 |
| 98 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.58159815 |
| 99 | Acanthosis nigricans (HP:0000956) | 1.58109809 |
| 100 | Neonatal death (HP:0003811) | 1.57294863 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FGFR4 | 4.54427892 |
| 2 | ERN1 | 4.50615038 |
| 3 | IRAK3 | 3.01118631 |
| 4 | PDGFRA | 2.96982379 |
| 5 | MST1R | 2.91721271 |
| 6 | DDR2 | 2.80457417 |
| 7 | RIPK1 | 2.71586482 |
| 8 | ICK | 2.54884066 |
| 9 | ERBB4 | 2.51481558 |
| 10 | FGFR3 | 2.48363996 |
| 11 | LATS2 | 2.29069371 |
| 12 | TRIB3 | 2.06673991 |
| 13 | SIK1 | 2.04033997 |
| 14 | EPHA3 | 1.89403920 |
| 15 | TGFBR2 | 1.85025491 |
| 16 | MET | 1.75645613 |
| 17 | EPHA2 | 1.75588770 |
| 18 | MAPKAPK3 | 1.72092358 |
| 19 | TESK1 | 1.65370850 |
| 20 | LATS1 | 1.60188784 |
| 21 | PRKAA2 | 1.48445249 |
| 22 | MAP3K3 | 1.47728712 |
| 23 | MYLK | 1.45564083 |
| 24 | MAP3K2 | 1.34348572 |
| 25 | NEK9 | 1.32229688 |
| 26 | MAP3K12 | 1.21029579 |
| 27 | TBK1 | 1.18478447 |
| 28 | SCYL2 | 1.18103454 |
| 29 | ABL2 | 1.17679547 |
| 30 | NTRK1 | 1.12104839 |
| 31 | LMTK2 | 1.10882607 |
| 32 | STK38 | 1.08705822 |
| 33 | CDC42BPA | 1.04801553 |
| 34 | MAPK11 | 1.04689440 |
| 35 | EIF2AK1 | 1.02402252 |
| 36 | PDPK1 | 1.01017701 |
| 37 | EPHB1 | 1.00982326 |
| 38 | TYRO3 | 1.00358658 |
| 39 | PTK2 | 0.94454412 |
| 40 | KSR2 | 0.89210424 |
| 41 | PDGFRB | 0.88789552 |
| 42 | ARAF | 0.87486568 |
| 43 | ACVR1B | 0.85320842 |
| 44 | MAP3K6 | 0.84101021 |
| 45 | PAK4 | 0.79309093 |
| 46 | CDK12 | 0.79133872 |
| 47 | RET | 0.75387963 |
| 48 | TYK2 | 0.75038928 |
| 49 | PRKACG | 0.73549274 |
| 50 | FER | 0.72825459 |
| 51 | MAP3K1 | 0.71449449 |
| 52 | PIM2 | 0.71195896 |
| 53 | DYRK1B | 0.67173407 |
| 54 | PIK3CA | 0.66623355 |
| 55 | PRKAA1 | 0.65246750 |
| 56 | MAPKAPK5 | 0.64398251 |
| 57 | EEF2K | 0.64220626 |
| 58 | CDK6 | 0.62409448 |
| 59 | PIK3CG | 0.61593071 |
| 60 | IGF1R | 0.60299085 |
| 61 | PRPF4B | 0.58520320 |
| 62 | PBK | 0.58057976 |
| 63 | PKN2 | 0.57068499 |
| 64 | WNK4 | 0.54515886 |
| 65 | MAPK15 | 0.54191186 |
| 66 | PRKG2 | 0.53638321 |
| 67 | TAOK2 | 0.53418695 |
| 68 | MAP2K1 | 0.52815548 |
| 69 | FGFR1 | 0.52577957 |
| 70 | CDK9 | 0.52171745 |
| 71 | JAK1 | 0.52169911 |
| 72 | FLT3 | 0.49831267 |
| 73 | TRPM7 | 0.49561960 |
| 74 | MTOR | 0.48903591 |
| 75 | GSK3A | 0.48627797 |
| 76 | MATK | 0.48267699 |
| 77 | PAK2 | 0.47968198 |
| 78 | WNK1 | 0.47864335 |
| 79 | EPHB2 | 0.47794610 |
| 80 | ZAP70 | 0.47763148 |
| 81 | STK38L | 0.47743572 |
| 82 | ERBB2 | 0.46520649 |
| 83 | AKT3 | 0.46287009 |
| 84 | LIMK1 | 0.45001794 |
| 85 | MAP3K7 | 0.44794519 |
| 86 | GRK5 | 0.42638046 |
| 87 | NLK | 0.42187370 |
| 88 | MAP2K3 | 0.41509729 |
| 89 | SRC | 0.40484169 |
| 90 | MAP2K4 | 0.38926768 |
| 91 | SGK223 | 0.38215451 |
| 92 | SGK494 | 0.38215451 |
| 93 | SGK3 | 0.37817532 |
| 94 | GRK1 | 0.37638243 |
| 95 | BMX | 0.37279556 |
| 96 | CAMK1D | 0.34859907 |
| 97 | IRAK1 | 0.34731813 |
| 98 | AKT2 | 0.34059951 |
| 99 | MAP3K9 | 0.33831618 |
| 100 | PDK2 | 0.33137687 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 4.15693147 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.71426663 |
| 3 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.60170289 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.10535213 |
| 5 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.01375508 |
| 6 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.96394471 |
| 7 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.89419352 |
| 8 | * Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.81435499 |
| 9 | Retinol metabolism_Homo sapiens_hsa00830 | 2.78078043 |
| 10 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.75930851 |
| 11 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.73576239 |
| 12 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.36021031 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.32933781 |
| 14 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.26765032 |
| 15 | Histidine metabolism_Homo sapiens_hsa00340 | 2.23577672 |
| 16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.18382005 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.13055423 |
| 18 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.04297959 |
| 19 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.01714427 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.94909473 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.93542806 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.76033647 |
| 23 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.55894520 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.54319605 |
| 25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.51776755 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.50339806 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.45850506 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37616174 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.32200910 |
| 30 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.27390692 |
| 31 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.23848628 |
| 32 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.22453964 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.22331346 |
| 34 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.22299513 |
| 35 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.21483198 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.17441466 |
| 37 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.12325947 |
| 38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.10727940 |
| 39 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.09655833 |
| 40 | Peroxisome_Homo sapiens_hsa04146 | 1.09386915 |
| 41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.03559552 |
| 42 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.03332297 |
| 43 | ABC transporters_Homo sapiens_hsa02010 | 1.02219341 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.02055556 |
| 45 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.01520405 |
| 46 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.96534875 |
| 47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.96349969 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.96258865 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.95812375 |
| 50 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.93521571 |
| 51 | Galactose metabolism_Homo sapiens_hsa00052 | 0.92567288 |
| 52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.91735584 |
| 53 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.91295225 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.89291080 |
| 55 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.86620650 |
| 56 | Other glycan degradation_Homo sapiens_hsa00511 | 0.80771935 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.79778520 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.74512475 |
| 59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.69912157 |
| 60 | Prion diseases_Homo sapiens_hsa05020 | 0.68822509 |
| 61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.66769863 |
| 62 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.66636172 |
| 63 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66352497 |
| 64 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.60589825 |
| 65 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.59001548 |
| 66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.58526115 |
| 67 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.48783799 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46457680 |
| 69 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.45060643 |
| 70 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.44654469 |
| 71 | Sulfur relay system_Homo sapiens_hsa04122 | 0.42809953 |
| 72 | Lysine degradation_Homo sapiens_hsa00310 | 0.42739858 |
| 73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40870728 |
| 74 | Pertussis_Homo sapiens_hsa05133 | 0.38075370 |
| 75 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.36402873 |
| 76 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.35797640 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.34175239 |
| 78 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.31677237 |
| 79 | Mineral absorption_Homo sapiens_hsa04978 | 0.31476930 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.30103965 |
| 81 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.27223754 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.23824170 |
| 83 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23251406 |
| 84 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.23199657 |
| 85 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.20652854 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.18265101 |
| 87 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.18200556 |
| 88 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.16046465 |
| 89 | Lysosome_Homo sapiens_hsa04142 | 0.14708010 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.08409286 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.07808681 |
| 92 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.06790638 |
| 93 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.06727588 |
| 94 | Amoebiasis_Homo sapiens_hsa05146 | 0.04635442 |
| 95 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.02620673 |
| 96 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.02444718 |
| 97 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.02182830 |
| 98 | Focal adhesion_Homo sapiens_hsa04510 | 0.01394278 |
| 99 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.0524733 |
| 100 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0334866 |

